Literature DB >> 23680381

Polysaccharide-based nucleic acid nanoformulations.

Koen Raemdonck1, Thomas F Martens, Kevin Braeckmans, Jo Demeester, Stefaan C De Smedt.   

Abstract

Therapeutic application of nucleic acids requires their encapsulation in nanosized carriers that enable safe and efficient intracellular delivery. Before the desired site of action is reached, drug-loaded nanoparticles (nanomedicines) encounter numerous extra- and intracellular barriers. Judicious nanocarrier design is highly needed to stimulate nucleic acid delivery across these barriers and maximize the therapeutic benefit. Natural polysaccharides are widely used for biomedical and pharmaceutical applications due to their inherent biocompatibility. At present, there is a growing interest in applying these biopolymers for the development of nanomedicines. This review highlights various polysaccharides and their derivatives, currently employed in the design of nucleic acid nanocarriers. In particular, recent progress made in polysaccharide-assisted nucleic acid delivery is summarized and the specific benefits that polysaccharides might offer to improve the delivery process are critically discussed.
Copyright © 2013 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Chitosan; Cyclodextrin; Dextran; Gene therapy; Hyaluronic acid; Nanomedicine; Plasmid DNA; siRNA

Mesh:

Substances:

Year:  2013        PMID: 23680381     DOI: 10.1016/j.addr.2013.05.002

Source DB:  PubMed          Journal:  Adv Drug Deliv Rev        ISSN: 0169-409X            Impact factor:   15.470


  20 in total

1.  Effect of low-intensity pulsed ultrasound on biocompatibility and cellular uptake of chitosan-tripolyphosphate nanoparticles.

Authors:  Junyi Wu; Gaojun Liu; Yi-Xian Qin; Yizhi Meng
Journal:  Biointerphases       Date:  2014-09       Impact factor: 2.456

Review 2.  Rekindling RNAi Therapy: Materials Design Requirements for In Vivo siRNA Delivery.

Authors:  Byungji Kim; Ji-Ho Park; Michael J Sailor
Journal:  Adv Mater       Date:  2019-09-30       Impact factor: 30.849

Review 3.  Membrane-core nanoparticles for cancer nanomedicine.

Authors:  Jianfeng Guo; Leaf Huang
Journal:  Adv Drug Deliv Rev       Date:  2020-05-22       Impact factor: 15.470

4.  Post-transcriptional silencing of myostatin-1 in the spotted rose snapper (Lutjanus guttatus) promotes muscle hypertrophy.

Authors:  Julia Torres-Velarde; Raúl Llera-Herrera; Leonardo Ibarra-Castro; Teresa García-Gasca; Alejandra García-Gasca
Journal:  Mol Biol Rep       Date:  2019-10-21       Impact factor: 2.316

5.  Cationic β-Cyclodextrin-Chitosan Conjugates as Potential Carrier for pmCherry-C1 Gene Delivery.

Authors:  Touba Eslaminejad; Seyed Noureddin Nematollahi-Mahani; Mehdi Ansari
Journal:  Mol Biotechnol       Date:  2016-04       Impact factor: 2.695

Review 6.  MicroRNA delivery for regenerative medicine.

Authors:  Bo Peng; Yongming Chen; Kam W Leong
Journal:  Adv Drug Deliv Rev       Date:  2015-05-27       Impact factor: 15.470

Review 7.  Nanoparticle-based technologies for retinal gene therapy.

Authors:  Jeffrey Adijanto; Muna I Naash
Journal:  Eur J Pharm Biopharm       Date:  2015-01-12       Impact factor: 5.571

8.  Chitosan nanoparticle-mediated effect of antimiRNA-324-5p on decreasing the ovarian cancer cell proliferation by regulation of GLI1 expression.

Authors:  Ysrafil Ysrafil; Indwiani Astuti
Journal:  Bioimpacts       Date:  2021-11-29

Review 9.  Nanoparticle delivery of antisense oligonucleotides and their application in the exon skipping strategy for Duchenne muscular dystrophy.

Authors:  Maria Sofia Falzarano; Chiara Passarelli; Alessandra Ferlini
Journal:  Nucleic Acid Ther       Date:  2014-02       Impact factor: 5.486

Review 10.  RNA interference-based nanosystems for inflammatory bowel disease therapy.

Authors:  Jian Guo; Xiaojing Jiang; Shuangying Gui
Journal:  Int J Nanomedicine       Date:  2016-10-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.